2020
DOI: 10.3390/diagnostics11010025
|View full text |Cite
|
Sign up to set email alerts
|

Hypodiploid B-Lymphoblastic Leukemia Presenting as an Isolated Orbital Mass Prior to Systemic Involvement: A Case Report and Review of the Literature

Abstract: We describe a 4-year-old boy who presented with progressive right periorbital edema and proptosis, with no systemic symptoms, who was found to have B-lymphoblastic leukemia (B-ALL). Magnetic resonance imaging (MRI) showed an enhancing mass centered in the right superolateral extraconal orbit. Orbital biopsy was consistent with B-ALL (CD99, TdT, LCA cocktail, CD34, CD79, CD10, PAX5, MIB1 positive; CD3, CD20 negative). A subsequent bone marrow aspirate confirmed a diagnosis of B-ALL with 80% blasts by flow cytom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…The oncological outcome of these patients does not differ from the patients who do not have orbital involvement. 22 23 24 25 26…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The oncological outcome of these patients does not differ from the patients who do not have orbital involvement. 22 23 24 25 26…”
Section: Discussionmentioning
confidence: 99%
“…A summary of selected reports of childhood ALL with proptosis is presented in ►Table 2. [22][23][24][25][26] Notably, three of six cases, including the current one, had associated intracranial or optic nerve involvement, translating to CNS positivity. Proptosis may be the presenting manifestation of precursor B-or T-lineage ALL affecting infants, children, or adolescents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Blinatumomab, a BiTE antibody that directs T-cells to CD19-positive cells, has proven to be effective in adult patients with low-hypodiploid B-ALL, with 2 of the 4 patients reaching a complete response in one study [ 78 ]. It has also been used as an additional therapeutic approach in high-risk group protocols, which may induce a more in-depth response in these groups of B-ALL [ 79 ]. On the other hand, studies treating patients with inotuzumab ozogamicin, a humanized anti-CD22 antibody-drug conjugate, have not shown any specific high efficacy in patients with hypodiploid B-ALL [ 80 ].…”
Section: Outcome and Treatment Strategies For B-all With Hypodiploidies <40 Chromosomesmentioning
confidence: 99%
“…ALL is the most common childhood variant of leukaemia; it generally presents with pancytopenia and organ infiltrates [3]. Despite the high survival rate following diagnosis, it is still a considerable cause of hospitalization and fatality in childhood populations [4].…”
Section: Introductionmentioning
confidence: 99%